Business

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

Financial Post · September 11, 2026 at 8:32 a.m.

NEW YORK, Sept.

11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio @ IBN ( InvestorBrandNetwork ) , a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

More from Financial Post

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment

Notice of Second Court Hearing

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions

Silver Is Headed for a Sixth Straight Year of Supply Shortfall

More in Business

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment

Notice of Second Court Hearing

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions

Silver Is Headed for a Sixth Straight Year of Supply Shortfall

Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale

BetterUp Canada Inc. Debuts Groundbreaking Study for Ontario First Responders